66. IgA腎症 IgA nephropathy Clinical trials / Disease details


臨床試験数 : 255 薬物数 : 255 - (DrugBank : 79) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 137

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04905212
(ClinicalTrials.gov)
November 4, 202121/5/2021A Study of Telitacicept for Injection (RC18) in Subjects With IgA NephropathyA Phase 2, Randomized, Double-Blind, Multicenter Study of Telitacicept for Injection (RC18) in Subjects With IgA NephropathyIgA NephropathyDrug: Telitacicept 160mg;Drug: Telitacicept 240mg;Drug: PlaceboRemeGen Co., Ltd.NULLRecruiting18 Years70 YearsAll30Phase 2United States